These findings together indicate that Dok-3 deficiency that drives malignant conversion of benign tumors had no apparent effect on mutagenesis in tumors, suggesting a mutagenesis-independent progression of malignancy induced by non-tumor cells. This evidence concerns the gene DOK3 and neoplasm.